Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-dose Alemtuzumab-Cyclosporine vs Tacrolimus-Methotrexate-Sirolimus for Chronic Graft-versus-Host Disease Prevention.
Holtzman NG, Curtis LM, Salit RB, Shaffer BC, Pirsl F, Ostojic A, Steinberg SM, Schulz E, Wilder JS, Hughes TE, Rose J, Memon S, Korngold R, Gea-Banacloche J, Fowler DH, Hakim FT, Gress RE, Bishop MR, Pavletic SZ. Holtzman NG, et al. Blood Adv. 2024 Apr 26:bloodadvances.2023010973. doi: 10.1182/bloodadvances.2023010973. Online ahead of print. Blood Adv. 2024. PMID: 38669315
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.
Curtis LM, Ostojic A, Venzon DJ, Holtzman NG, Pirsl F, Kuzmina ZJ, Baird K, Rose JJ, Cowen EW, Mays JW, Mitchell SA, Parsons-Wandell L, Joe GO, Comis LE, Berger A, Pusic I, Peer CJ, Figg WD, Cao L, Gale RP, Hakim FT, Pavletic SZ. Curtis LM, et al. Among authors: holtzman ng. Blood. 2021 Feb 18;137(7):896-907. doi: 10.1182/blood.2020006892. Blood. 2021. PMID: 32976576 Free PMC article. Clinical Trial.
W"H-Y" antigen/HLA complexes in chronic GVHD.
Holtzman NG, Pavletic SZ. Holtzman NG, et al. Blood. 2023 Sep 14;142(11):946-948. doi: 10.1182/blood.2023021357. Blood. 2023. PMID: 37707875 No abstract available.
Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosis.
Goklemez S, Im AP, Cao L, Pirsl F, Steinberg SM, Curtis LM, Mitchell SA, Cowen EW, Baruffaldi J, Rose J, Mays J, Ostojic A, Holtzman NG, Hakim FT, Pavletic SZ. Goklemez S, et al. Among authors: holtzman ng. Am J Hematol. 2020 Apr;95(4):387-394. doi: 10.1002/ajh.25717. Epub 2020 Jan 25. Am J Hematol. 2020. PMID: 31903638 Free PMC article.
Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease.
Ruben CL, Pirsl F, Steinberg SM, Holtzman NG, Parsons-Wandell L, Baruffaldi J, Curtis LM, Mitchell SA, Kerep AZ, Cowen EW, Berger A, Joe GO, Datiles MB 3rd, Mays JW, Pavletic SZ. Ruben CL, et al. Among authors: holtzman ng. Bone Marrow Transplant. 2021 Jul;56(7):1584-1592. doi: 10.1038/s41409-021-01211-2. Epub 2021 Feb 1. Bone Marrow Transplant. 2021. PMID: 33526918 Free PMC article.
Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.
Goklemez S, Saligan LN, Pirsl F, Holtzman NG, Ostojic A, Steinberg SM, Hakim FT, Rose JJ, Kang Z, Yu Y, Cao L, Mitchell SA, Im A, Pavletic SZ. Goklemez S, et al. Among authors: holtzman ng. Bone Marrow Transplant. 2021 Dec;56(12):2934-2939. doi: 10.1038/s41409-021-01419-2. Epub 2021 Aug 25. Bone Marrow Transplant. 2021. PMID: 34433916 Free PMC article.
Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host Disease.
Zelic Kerep A, Pirsl F, Steinberg S, Mitchell S, Curtis L, Holtzman N, Goklemez S, Bilic E, Cowen E, Pichard D, Joe G, Comis L, Im A, Berger A, Parsons-Wandell L, Pulanic D, Baird K, Gress R, Pavletic S. Zelic Kerep A, et al. Hemasphere. 2022 May 31;6(6):e730. doi: 10.1097/HS9.0000000000000730. eCollection 2022 Jun. Hemasphere. 2022. PMID: 35747850 Free PMC article.
51 results